Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
08/04/2025 09:16
April 8 (Reuters) - Lyka Labs Ltd LYKA.NS: LYKA LABS LTD - GRANTED INDIAN PATENT FOR PREGABALIN GEL 8% VALID THROUGH 2043 Source text: ID:nBSEc52BVY Further company coverage: LYKA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lyka Labs
See all newsBrief: Lyka Labs Gets Tribunal Order To Receive 6.3 Million Rupees From Modi Life Care
Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge
India's Lyka Labs climbs after regulatory body approves Pregabalin Gel
Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India